|
J Biol Chem, Vol. 274, Issue 34, 23691-23694, August 20, 1999
COMMUNICATION
A Candidate U1 Small Nuclear RNA for Trypanosomatid Protozoa*
Murray N.
Schnare and
Michael W.
Gray
From the Department of Biochemistry and Molecular Biology,
Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada
 |
ABSTRACT |
In trypanosomatid protozoa, all mRNAs obtain
identical 5'-ends by trans-splicing of the 5'-terminal 39 nucleotides of a small spliced leader RNA to appropriate acceptor sites
in pre-mRNA. Although this process involves spliceosomal small
nuclear (sn) RNAs, it is thought that trypanosomatids do not contain a
homolog of the cis-spliceosomal U1 snRNA. We show here that
a trypanosomatid protozoon, Crithidia fasciculata, contains
a novel small RNA that displays several features characteristic of a U1
snRNA, including (i) a methylguanosine cap and additional 5'-terminal
modifications, (ii) a potential binding site for common core proteins
that are present in other trans-spliceosomal
ribonucleoproteins, (iii) a U1-like 5'-terminal sequence, and (iv) a
U1-like stem/loop I structure. Because trypanosomatid pre-mRNAs do
not appear to contain cis-spliced introns, we argue that
this previously unrecognized RNA species is a good candidate to be a
trans-spliceosomal U1 snRNA.
 |
INTRODUCTION |
In trypanosomatid protozoa, all mRNAs have identical
5'-terminal sequences. A 39-nucleotide
(nt)1 spliced leader (SL)
sequence is transferred from the 5'-end of a small SL RNA to the
pre-mRNA in a process known as trans-splicing, which is
very similar to the spliceosomal cis-splicing found in other
eukaryotes (1). However, it is thought that trypanosomes and their
relatives contain neither cis-spliced introns (1, 2) nor an
equivalent of the U1 small nuclear (sn) RNA required for spliceosomal
cis-splicing (3). The SL RNA is considered to be a
trans-spliceosome-specific snRNA because it is found in a
ribonucleoprotein particle that contains the same core proteins that
are associated with other trans-spliceosomal snRNAs (4, 5).
It has been proposed that during trans-splicing, sequences within the SL RNA are able to substitute for the function that U1 snRNA
normally supplies in cis-splicing (3, 6, 7). Our discovery
of a U1 snRNA homolog in Euglena gracilis (8), an organism
that is specifically related to trypanosomatid protozoa (9), prompted
us to re-evaluate a possible role for U1 snRNA in trypanosomatids.
In cis-splicing, during early stages of spliceosome
assembly, the 5'-terminal region of U1 snRNA base pairs across the
5'-splice site (10). In the case of trans-splicing, it is
commonly held that base pairing between U1 snRNA and the 5'-splice site
may not be required for splicing of SL RNA sequences (1, 3, 6, 7). This
view is supported by a study in which a trypanosomatid (Leptomonas collosoma) SL RNA sequence was placed upstream
of a 3'-splice site, with the resulting chimeric substrate being efficiently spliced in a HeLa cell nuclear extract even after the
5'-end of >99% of the endogenous U1 snRNA had been removed by
oligonucleotide-directed RNase H cleavage (7). This result provided
support for an earlier proposal that U1 snRNA-like base pairing could
be supplied by a region of the SL RNA upstream of the 5'-splice site
(6). However, it was subsequently shown that U1 snRNP is, in fact,
required for cis-splicing of the chimeric substrate, and
that base pairing between the 5'-end of U1 snRNA and the SL RNA
5'-splice site does occur in these extracts when the 5'-end of U1 snRNA
is intact (11). It has also been demonstrated recently that the
proposed internal SL RNA base pairing across the 5'-splice site is not
essential for trans-splicing in Leishmania tarentolae (12). In sum, the proposal that trypanosomatid SL RNA
substitutes for U1 snRNA in trans-splicing has not gained experimental support, and the data do not definitively rule out the
possibility that a U1 snRNA homolog is present in trypanosomatid protozoa but has not yet been identified. Here we show that a representative trypanosomatid, Crithidia fasciculata,
contains a novel small RNA that displays several characteristic
features expected of a U1 snRNA homolog.
 |
EXPERIMENTAL PROCEDURES |
Immunoprecipitation (3)--
100 µl of 2 × buffer
(1 × buffer = 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1.0 mM EDTA, 0.05% (v/v) Nonidet
P-40) and 50 µl (5 µg) of
anti-N2,N2,7-trimethylguanosine
(m32,2,7G) monoclonal antibody (Oncogene Research
Products, Ref. 13) were added to 50 µl (250 µg) of total RNA
(prepared as described, see Ref. 14). After 1 h on ice, protein
A-Sepharose (Amersham Pharmacia Biotech, 3 mg in 100 µl of 1 × buffer) was added, and the sample was incubated on ice (30 min) with
occasional mixing. The immunoprecipitate was recovered by
centrifugation (5 min) and washed (five times) by resuspension in 1 ml
of 1 × buffer followed by centrifugation. The final pellet was
resuspended in 200 µl of H2O, 20 µl of 3.0 M NaOAc were added, and RNA was recovered by extraction
with phenol-cresol (twice) followed by ethanol precipitation. Contaminating rRNA was removed by repeating the above
immunoprecipitation procedure.
Amplification of DNA--
The following primers were used in
polymerase chain reaction (PCR) experiments (8, 15): CfU1A
(5'-CCCTCAAAATATGCTGCGAC-3'), CfU1 (5'-ATCAAGAAAGCACCAAGTCG-3'), 3'ARG
(5'-ATCCGTGACAGGATTCGAAC-3'), 5'LEU
(5'-AGATGGTCGAGTGGTCTAAG-3'). A reverse transcriptase (RT)-PCR product
was generated (16, 17) by first polyadenylating total RNA using yeast
poly(A) polymerase followed by reverse transcription using primer P-94
(5'-AATAAAGCGGCCGCGGATCCAATTTTTTTTTTTTTTTTT(G/A/C)-3'). A specific
product was obtained after two rounds of PCR; primary PCR employed
primer P-55 (5'-GGAGCTCAATAAAGCGGCCGC-3') and primer CfU1, while
secondary PCR employed primer P-4 (5'-AATAAAGCGGCCGCGGATCCAA-3') and
primer CfU1.
Sequence Analysis--
5'-End-labeled PCR and RT-PCR products,
as well as an RT product generated using 5'-end-labeled primer CfU1A,
were sequenced by a modified chemical
method.2 RNA was labeled with
32P at either the 5' or 3' end, sequenced by chemical and
enzymatic methods, and subjected to terminal nucleotide analysis
as described (8, 15, 18).
 |
RESULTS AND DISCUSSION |
Antibodies specific for m32,2,7G have been used to
enrich for capped snRNAs in Trypanosoma brucei (3). Although
no U1 snRNA homolog was found among the four largest
m32,2,7G-capped RNAs, the experiments did detect other,
smaller capped RNAs that were not further characterized (3). Additional
snRNAs have also been detected by immunoprecipitation using
antibodies directed against core proteins common to T. brucei spliceosomal snRNPs (5). Fig.
1 shows an electrophoretic profile of
C. fasciculata RNAs that were immunoprecipitated using a
monoclonal anti-m32,2,7G antibody. The antibody reacted
efficiently with homologs of the m32,2,7G-capped RNAs
identified previously in T. brucei. It also reacted efficiently with the 7-monomethylguanosine (m7G)-capped SL
RNA (20) and with an intermediate of the trans-splicing reaction, the 39-nt free SL RNA exon. In addition, the antibody enriched for a subset of tRNAs that appear to have internal
m7G in their variable loops, as judged by chemical
reactivity during sequencing. When the amount of antibody relative to
RNA was reduced in immunoprecipitation experiments, the RNA yield
decreased but the intensity of individual bands relative to each other
remained unchanged (data not shown). Although the monoclonal antibody
did not distinguish between m7G and
m32,2,7G caps, this procedure did allow us to identify
a previously unrecognized methylguanosine (mG)-capped RNA that was
present at approximately the same concentration as the known
trans-spliceosomal snRNAs (U1 snRNA? in Fig.
1).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Anti-m32,2,7G
immunoprecipitation of capped RNAs from C. fasciculata. RNAs were 3'-end-labeled and resolved in a
10% polyacrylamide, 7 M urea sequencing gel. Individual
RNAs were identified by partial sequence analysis and comparison to
known sequences. sno = small nucleolar. Notes:
(a) the three U6 snRNA bands have identical 3' termini (19)
and are immunoprecipitated due to base pairing with mG-capped U4 snRNA
(3); denaturation of the sample (90 °C, 2 min) prior to
immunoprecipitation greatly reduces the yield of U6 snRNA.
(b) The yield of tRNAs is greatly increased by prior heat
treatment (65 °C, 5 min). (c) The yield of tRNA fragments
varies for different RNA preparations. (d) The 5'-terminal
tRNAAsn fragment ends at the 5-methyluridine at position
54. (e) The 3'-terminal tRNATyr fragment starts
at position A9. (f) The four SL RNAs (20-22) end at
positions G83, U90, G91, and C92.
|
|
When the preliminary sequence of this candidate U1 snRNA was used as a
query in a GenBankTM search, we detected a similar sequence
in a tRNA gene cluster from L. tarentolae (23), located on
the opposite strand between upstream tRNAArg and downstream
tRNALeu genes. PCR experiments (primer combination CfU1A
and 3'ARG, see "Experimental Procedures") confirmed that in
C. fasciculata there is also a tRNAArg gene on
the opposite strand ~100 base pairs upstream of the candidate U1
snRNA sequence. Attempts to amplify the region in C. fasciculata DNA between this new sequence and a possible
downstream tRNALeu gene (primer combination CfU1 and 5'LEU,
see "Experimental Procedures") were unsuccessful, indicating that
this particular gene linkage may not be conserved between L. tarentolae and C. fasciculata.
The first two residues of the novel RNA were identified as A by DNA
sequencing (Fig. 2A) but were
resistant to cleavage by RNases and alkali during enzymatic sequencing
(not shown), indicating that they are
O2'-methylated. The first residue was also
resistant to cleavage in the A reaction during chemical sequencing
(Fig. 2B), suggesting that it contains additional
modifications. No other post-transcriptional modifications were
encountered during sequencing, but we did detect a single site of
heterogeneity, A/C at position 60 (Fig. 2, C and
D).

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 2.
Sequence analysis of a potential U1 snRNA
from C. fasciculata. A, chemical
sequencing of a PCR product generated in the presence of 5'-end-labeled
primer CfU1A and unlabeled primer 3'-ARG. B and
D, chemical sequencing of 3'-end-labeled RNA prepared as in
Fig. 1. C, chemical sequencing of an RT-PCR product
generated in the presence of 5'-end-labeled primer CfU1. The
A lanes in these sequencing gels represent chemical cleavage
of A > G.
|
|
In order to further characterize the modified A at the 5'-end of the
molecule, the RNA was 5'-end-labeled after removal of the mG cap
structure by tobacco acid pyrophosphatase treatment. Gel-purified RNA
was digested with snake venom phosphodiesterase, and the resulting
radioactive mononucleotide was analyzed by thin layer chromatography.
This experiment (Fig. 3, A and
B) demonstrates that the candidate U1 snRNA has the same
hypermodified 5'-terminal nucleoside,
(N6,N6,O2'-trimethyladenosine
(m26Am)) that is known to be present at the 5'-end of
SL RNAs from C. fasciculata and T. brucei (20);
in contrast, the U2 (Fig. 3A) and U4 (not shown) snRNAs have
5'-terminal O2'-methyladenosine (Am) residues.
The similarity in methylation patterns observed between this new RNA
and the SL RNA may be explained by the fact that six of the seven
5'-terminal nucleotides are identical in the two RNA species (Fig.
3C).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 3.
5'-Terminal modified nucleotide
analysis. Thin layer chromatography was carried out using
unlabeled pN and pAm as markers. Co-migration of the SL and U1?
products was verified by eluting them from the original plate
(A) and re-chromatographing them (B) using less
of the SL RNA sample with the same solvent system (95%
ethanol:H2O, 4:1, Ref. 18). Co-migration was also observed
in a second solvent system (saturated ammonium sulfate:isopropanol,
40:1, Ref. 18; not shown). C, comparison of the 5'-terminal
sequences of C. fasciculata U1 snRNA? and SL RNA (20-22).
Note that the modifications present at positions three
(O2'-methylcytosine, Cm) and four
(3,O2'-dimethyluridine, m3Um) of the
SL RNA are readily detected in RNA sequencing reactions (not shown) and
on this basis are clearly not present in the candidate U1 snRNA.
Terminal mG caps are not included.
|
|
Trypanosomatid snRNAs contain sequences that bind spliceosomal core
proteins (4-6, 24, 25). The C. fasciculata SL RNA core-protein binding site, which is capable of interacting with mammalian Sm proteins (6) as well as with T. brucei core
proteins (4), appears to consist of an AAAUUUUGA sequence followed by a
short G + C-rich hairpin. The novel RNA reported here has an almost
identical sequence, AUAUUUUGA (residues 44-52), followed by a
3'-terminal hairpin structure that is supported by compensating base
changes in the L. tarentolae sequence (Fig.
4B).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Comparison of the C. fasciculata
candidate U1 snRNA with known U1 snRNAs. A,
secondary structure (26) of Homo sapiens U1 snRNA (27, 28)
showing the locations of modified nucleosides (Um = O2'-methyluridine, = pseudouridine) and
the Sm core-protein binding site. B, potential secondary
structure of the C. fasciculata RNA showing differences in
its homolog from L. tarentolae (circled residues
next to the C. fasciculata sequence). A
trypanosomatid-specific spliceosomal core-protein (CP)
binding site, analogous to the Sm site in higher eukaryotes, is
indicated (Sm/CP site). C, 5'-terminal sections
of the C. fasciculata (C.f.) nucleotide sequence
are compared with the corresponding sections of U1 snRNA sequences (8,
29) from Euglena gracilis (E.g.), Physarum
polycephalum (P.p.), Saccharomyces
cerevisiae (S.c.), and H. sapiens
(H.s.). Dots represent residues that are
identical to the C. fasciculata sequence. The loop region of
stem/loop I is enclosed by parentheses. Secondary structure
diagrams were generated using the program XRNA developed by B. Weiser
and H. Noller (University of California, Santa Cruz, CA).
|
|
The presence of a core-protein binding site and a modified 5' terminus,
both of which are specifically related to their
trans-spliceosomal SL RNA counterparts, provides strong
evidence that this new capped RNA is also a component of the
trans-spliceosome. Given that U1 snRNA is the only typical
spliceosomal snRNA that has not yet been discovered in trypanosomatid
protozoa (3, 24, 25), it is not surprising that we also found primary
sequence conservation between this C. fasciculata candidate
U1 snRNA and known U1 snRNAs from other organisms (Fig. 4C;
compare Fig. 4, A and B). Notably, the highly
conserved 5'-terminal region contains the ACCU sequence (residues 6-9,
overlined in Fig. 4) that has the potential to interact with
conserved splice site sequences (10). The C. fasciculata candidate U1 snRNA also contains a stem/loop I sequence that, in
mammalian systems, is the binding site for U1-70K, a U1 snRNP-specific protein (30).
In view of the unusually small size of the C. fasciculata
candidate U1 snRNA (69 nt), it is also not surprising that it lacks some of the characteristic features of a U1 snRNA (Fig. 4, A
versus B). The highly conserved stem/loop II,
which serves as the binding site for the U1-A protein in other
eukaryotes (30), is the most notable structural element that is
missing. One could argue that stem/loop II functions are either
unnecessary for trans-splicing or are supplied by another
component of the spliceosome (RNA and/or protein). Other trypanosomatid
snRNAs show a similar pattern of reduced size and sequence
divergence compared with their homologs from other systems (1, 3, 19,
24, 25).
The presence of structurally divergent snRNAs in trypanosomatid
protozoa may indicate that the highly accurate splice site selection
required for cis-splicing systems may not be as important in
a "trans-splicing only" system (1). For example, the
demands on 5'-splice site selection machinery (including U1 snRNA) are considerably reduced in trans-splicing, where the 5'-splice
site is already present in the spliceosome as part of the spliceosomal SL RNA. Similarly, reduced accuracy of branch point and 3'-splice site
selection (1) in SL RNA trans-splicing (which occurs
upstream of coding sequences) is likely to be tolerated, because errors would not disrupt the reading frame in the spliced product (1). On the
other hand, with the discovery of an apparent U1 snRNA homolog,
trypanosomatid protozoa may possess a complete set of spliceosomal snRNAs, raising the possibility that the mechanisms of
trans- and cis-splicing are not as different as
was previously thought. In this regard, in the absence of a complete
genomic sequence, we cannot rule out the possibility that a least a few cis-spliced introns may eventually be found in the
trypanosomatid group of protozoa.
 |
ACKNOWLEDGEMENTS |
We thank F. B. St. C. Palmer and R. Breckon for supplying cultures of C. fasciculata, D. F. Spencer for a gift of purified C. fasciculata DNA and the
chemical sequencing protocol, and Y. Watanabe for the primers used
for RT-PCR.
 |
FOOTNOTES |
*
This work was supported by Grant MT-11212 (to M. W. G.) from the Medical Research Council of Canada and by a
fellowship (also to M. W. G.) from the Canadian Institute for Advanced
Research (Program in Evolutionary Biology).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF157481.
To whom all correspondence should be addressed. Tel.:
902-494-2521; Fax: 902-494-1355; E-mail: mwgray@is.dal.ca.
2
D. F. Spencer, unpublished protocol.
 |
ABBREVIATIONS |
The abbreviations used are:
nt, nucleotide;
SL, spliced leader;
sn, small nuclear;
PCR, polymerase chain reaction;
RT, reverse transcriptase;
m32,2,7G, N2,N2,7-trimethylguanosine;
m7G, 7-monomethylguanosine;
mG, methylguanosine;
m26Am, N6,N6,O2'-trimethyladenosine;
Am, O2'-methyladenosine.
 |
REFERENCES |
| 1.
|
Agabian, N.
(1990)
Cell
61,
1157-1160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Logsdon, J. M., Jr.
(1998)
Curr. Opin. Genet. Dev.
8,
637-648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Mottram, J.,
Perry, K. L.,
Lizardi, P. M.,
Lührmann, R.,
Agabian, N.,
and Nelson, R. G.
(1989)
Mol. Cell. Biol.
9,
1212-1223[Abstract/Free Full Text]
|
| 4.
|
Cross, M.,
Günzl, A.,
Palfi, Z.,
and Bindereif, A.
(1991)
Mol. Cell. Biol.
11,
5516-5526[Abstract/Free Full Text]
|
| 5.
|
Palfi, Z.,
and Bindereif, A.
(1992)
J. Biol. Chem.
267,
20159-20163[Abstract/Free Full Text]
|
| 6.
|
Bruzik, J. P.,
Van Doren, K.,
Hirsh, D.,
and Steitz, J. A.
(1988)
Nature
335,
559-562[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Bruzik, J. P.,
and Steitz, J. A.
(1990)
Cell
62,
889-899[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Breckenridge, D. G.,
Watanabe, Y.,
Greenwood, S. J.,
Gray, M. W.,
and Schnare, M. N.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
852-856[Abstract/Free Full Text]
|
| 9.
|
Sogin, M. L.
(1991)
Curr. Opin. Genet. Dev.
1,
457-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Ares, M., Jr.,
and Weiser, B.
(1995)
Prog. Nucleic Acid Res. Mol. Biol.
50,
131-159[Medline]
[Order article via Infotrieve]
|
| 11.
|
Seiwert, S. D.,
and Steitz, J. A.
(1993)
Mol. Cell. Biol.
13,
3135-3145[Abstract/Free Full Text]
|
| 12.
|
Sturm, N. R.,
Fleishmann, J.,
and Campbell, D. A.
(1998)
J. Biol. Chem.
273,
18689-18692[Abstract/Free Full Text]
|
| 13.
|
Krainer, A. R.
(1988)
Nucleic Acids Res.
16,
9415-9429[Abstract/Free Full Text]
|
| 14.
|
Gray, M. W.
(1979)
Can. J. Biochem.
57,
914-926[Medline]
[Order article via Infotrieve]
|
| 15.
|
Greenwood, S. J.,
Schnare, M. N.,
and Gray, M. W.
(1996)
Curr. Genet.
30,
338-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Zaug, A. J.,
Lingner, J.,
and Cech, T. R.
(1996)
Nucleic Acids Res.
24,
532-533[Free Full Text]
|
| 17.
|
Thweatt, R.,
Goldstein, S.,
and Shmookler Reis, R. J.
(1990)
Anal. Biochem.
190,
314-316[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
MacKay, R. M.,
Spencer, D. F.,
Doolittle, W. F.,
and Gray, M. W.
(1980)
Eur. J. Biochem.
112,
561-576[Medline]
[Order article via Infotrieve]
|
| 19.
|
Xu, G.-L.,
Wieland, B.,
and Bindereif, A.
(1994)
Mol. Cell. Biol.
14,
4565-4570[Abstract/Free Full Text]
|
| 20.
|
Bangs, J. D.,
Crain, P. F.,
Hashizume, T.,
McCloskey, J. A.,
and Boothroyd, J. C.
(1992)
J. Biol. Chem.
267,
9805-9815[Abstract/Free Full Text]
|
| 21.
|
Muhich, M. L.,
Hughes, D. E.,
Simpson, A. M.,
and Simpson, L.
(1987)
Nucleic Acids Res.
15,
3141-3153[Abstract/Free Full Text]
|
| 22.
|
Gabriel, A.,
Sisodia, S. S.,
and Cleveland, D. W.
(1987)
J. Biol. Chem.
262,
16192-16199[Abstract/Free Full Text]
|
| 23.
|
Shi, X.,
Chen, D.-H. T.,
and Suyama, Y.
(1994)
Mol. Biochem. Parasitol.
65,
23-37[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Dungan, J. M.,
Watkins, K. P.,
and Agabian, N.
(1996)
EMBO J.
15,
4016-4029[Medline]
[Order article via Infotrieve]
|
| 25.
|
Xu, Y.,
Ben-Shlomo, H.,
and Michaeli, S.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8473-8478[Abstract/Free Full Text]
|
| 26.
|
Guthrie, C.,
and Patterson, B.
(1988)
Annu. Rev. Genet.
22,
387-419[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Branlant, C.,
Krol, A.,
Ebel, J.-P.,
Lazar, E.,
Gallinaro, H.,
Jacob, M.,
Sri-Widada, J.,
and Jeanteur, P.
(1980)
Nucleic Acids Res.
8,
4143-4154[Abstract/Free Full Text]
|
| 28.
|
Reddy, R.,
Henning, D.,
and Busch, H.
(1981)
Biochem. Biophys. Res. Commun.
98,
1076-1083[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Zwieb, C.
(1997)
Nucleic Acids Res.
25,
102-103[Abstract/Free Full Text]
|
| 30.
|
Lührmann, R.,
Kastner, B.,
and Bach, M.
(1990)
Biochim. Biophys. Acta
1087,
265-292[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Mittra, J. R. Zamudio, J. M. Bujnicki, J. Stepinski, E. Darzynkiewicz, D. A. Campbell, and N. R. Sturm
The TbMTr1 Spliced Leader RNA Cap 1 2 '-O-Ribose Methyltransferase from Trypanosoma brucei Acts with Substrate Specificity
J. Biol. Chem.,
February 8, 2008;
283(6):
3161 - 3172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Zamudio, B. Mittra, S. Foldynova-Trantirkova, G. M. Zeiner, J. Lukes, J. M. Bujnicki, N. R. Sturm, and D. A. Campbell
The 2'-O-Ribose Methyltransferase for Cap 1 of Spliced Leader RNA and U1 Small Nuclear RNA in Trypanosoma brucei
Mol. Cell. Biol.,
September 1, 2007;
27(17):
6084 - 6092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Tkacz, Y. Lustig, M. Z. Stern, M. Biton, M. Salmon-Divon, A. Das, V. Bellofatto, and S. Michaeli
Identification of novel snRNA-specific Sm proteins that bind selectively to U2 and U4 snRNAs in Trypanosoma brucei
RNA,
January 1, 2007;
13(1):
30 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Zamudio, B. Mittra, G. M. Zeiner, M. Feder, J. M. Bujnicki, N. R. Sturm, and D. A. Campbell
Complete Cap 4 Formation Is Not Required for Viability in Trypanosoma brucei
Eukaryot. Cell,
June 1, 2006;
5(6):
905 - 915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Palfi, B. Schimanski, A. Gunzl, S. Lucke, and A. Bindereif
U1 small nuclear RNP from Trypanosoma brucei: a minimal U1 snRNA with unusual protein components
Nucleic Acids Res.,
April 29, 2005;
33(8):
2493 - 2503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-h. Liang, A. Haritan, S. Uliel, and S. Michaeli
trans and cis Splicing in Trypanosomatids: Mechanism, Factors, and Regulation
Eukaryot. Cell,
October 1, 2003;
2(5):
830 - 840.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gunzl, A. Bindereif, E. Ullu, and C. Tschudi
Determinants for cap trimethylation of the U2 small nuclear RNA are not conserved between Trypanosoma brucei and higher eukaryotic organisms
Nucleic Acids Res.,
October 1, 2000;
28(19):
3702 - 3709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Schnare, J. C. Collings, D. F. Spencer, and M. W. Gray
The 28S-18S rDNA intergenic spacer from Crithidia fasciculata: repeated sequences, length heterogeneity, putative processing sites and potential interactions between U3 small nucleolar RNA and the ribosomal RNA precursor
Nucleic Acids Res.,
September 15, 2000;
28(18):
3452 - 3461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Palfi, S. Lücke, H.-W. Lahm, W. S. Lane, V. Kruft, E. Bragado-Nilsson, B. Séraphin, and A. Bindereif
The spliceosomal snRNP core complex of Trypanosoma brucei: Cloning and functional analysis reveals seven Sm protein constituents
PNAS,
July 12, 2000;
(2000)
150236097.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y.-i. Watanabe and M. W. Gray
Evolutionary appearance of genes encoding proteins associated with box H/ACA snoRNAs: Cbf5p in Euglena gracilis, an early diverging eukaryote, and candidate Gar1p and Nop10p homologs in archaebacteria
Nucleic Acids Res.,
June 15, 2000;
28(12):
2342 - 2352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-x. Xu, L. Liu, and S. Michaeli
Functional Analyses of Positions across the 5' Splice Site of the Trypanosomatid Spliced Leader RNA. IMPLICATIONS FOR BASE-PAIR INTERACTION WITH U5 AND U6 snRNAs
J. Biol. Chem.,
September 1, 2000;
275(36):
27883 - 27892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Palfi, S. Lucke, H.-W. Lahm, W. S. Lane, V. Kruft, E. Bragado-Nilsson, B. Seraphin, and A. Bindereif
The spliceosomal snRNP core complex of Trypanosoma brucei: Cloning and functional analysis reveals seven Sm protein constituents
PNAS,
August 1, 2000;
97(16):
8967 - 8972.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|